drugset / Trial / NCT02061683

A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension

NCT02061683

Phase 4 Completed 263 enrolled Allergan
NaSingle-groupOpen-labelTreatment

Summary

This is a study of bimatoprost as initial, replacement, or adjunctive intraocular pressure (IOP)-lowering therapy in patients with primary open angle glaucoma and ocular hypertension.

Timeline

Start
2010-04-19
Primary completion
2011-06-24
Completion
2011-06-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.03 % Other